Sub-Tenon’s capsule triamcinolone acetonide injection to prevent brolucizumab-associated intraocular inflammation

被引：0
作者：
Taiichi Hikichi
机构：
[1] Hikichi Eye Clinic,
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2022年 / 260卷
关键词：
Anti-vascular endothelial growth factor therapy; Brolucizumab; Intraocular inflammation; Neovascular age-related macular degeneration; Triamcinolone acetonide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2529 / 2535
页数：6
相关论文
共 75 条
  • [1] Markham A(2019)Brolucizumab: first approval Drugs 79 1997-2000
  • [2] Dugel PU(2017)Brolucizumab versus aflibercept in participants with neovascular age-related macular degeneration: a randomized trial Ophthalmology 124 1296-1304
  • [3] Jaffe GJ(2016)Single-chain anti-body fragment VEGF inhibitor RTH258 for neovascular age-related macular degeneration: a randomized controlled study Ophthalmology 123 1080-1089
  • [4] Sallstig P(2020)HAWK and HARRIER: Phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration Ophthalmology 127 72-84
  • [5] Holz FG(2020)Occlusive retinal vasculitis following intravitreal brolucizumab J Vitreoretin Dis 4 269-279
  • [6] Dugel PU(2020)Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab Ophthalmology 127 1345-1359
  • [7] Weissgerber G(2021)Risk of inflammation, retinal vasculitis, and retinal occlusion related events with brolucizumab.Post hoc review of HAWK and HARRIER Ophthalmology 128 1050-9
  • [8] Dugel PU(2015)Disease burden in the treatment of age-related macular degeneration: findings from a time-and-motion study Am J Ophthalmol 160 725-731
  • [9] Koh A(2021)Three Japanese cases of intraocular inflammation after intravitreal brolucizumab injections in one clinic Jpn J Ophthalmol 65 208-214
  • [10] Ogura Y(2022)Clinical characteristics and outcomes of eyes with intraocular inflammation after brolucizumab: post hoc analysis of HAWK and HARRIER Ophthalmol Retina 6 97-108
12345678